Anandkumar Raichurkar
AstraZeneca (India)(IN)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Tuberculosis Research and Epidemiology, Biochemical and Molecular Research, Malaria Research and Control, Computational Drug Discovery Methods
Most-Cited Works
- → Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis(2017)124 cited
- → Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity(2014)93 cited
- → Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating Mycobacterium tuberculosis(2012)86 cited
- → Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate(2015)73 cited
- → Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B(2013)66 cited
- → Benzimidazoles: Novel Mycobacterial Gyrase Inhibitors from Scaffold Morphing(2014)57 cited
- → Novel N-Linked Aminopiperidine-Based Gyrase Inhibitors with Improved hERG and in Vivo Efficacy against Mycobacterium tuberculosis(2014)51 cited
- → Diarylthiazole: An Antimycobacterial Scaffold Potentially Targeting PrrB-PrrA Two-Component System(2014)47 cited
- → Structure Guided Lead Generation for M. tuberculosis Thymidylate Kinase (Mtb TMK): Discovery of 3-Cyanopyridone and 1,6-Naphthyridin-2-one as Potent Inhibitors(2014)44 cited
- → N-Aryl-2-aminobenzimidazoles: Novel, Efficacious, Antimalarial Lead Compounds(2014)41 cited